Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin for Erlotinib-induced Skin Rash
NCT01299220Phase 4Withdrawn
- Sponsor
- University of Pittsburgh
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of acitretin in cutaneous drug eruption (CADR), sponsored by University of Pittsburgh. Planned start Nov 2010; status: withdrawn.
02
Drugs
acitretin
03
Conditions
cutaneous drug eruption (CADR)
Beyond the preview
Go deeper on NCT01299220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299220.